BMRA vs MS · rev $5.3M vs P/E 20, $344.27B cap
Biomerica Inc (BMRA) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Biomerica Inc (BMRA) is a medical devices company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BMRA revenue for 2025-05-31 was $5.3M. Net income was -$5.0M. Revenue was down 1.9% from 2024-05-31 to 2025-05-31. BMRA currently screens at market cap $8.0M.
MS does not have a complete income-statement cache yet.
BMRA currently screens at market cap $8.0M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BMRA and MS stock pages for the full models.
Not investment advice.